# RyboDyn

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rybodyn

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.rybodyn.com/
- Total disclosed funding: $10M
- Latest round: Seed (Mar 24, 2026)
- Investors on record: 6

## About

Founded in 2022 and based in California, US, RyboDyn, Inc. drug discovery company that delivers specialized proteomic solutions, particularly addressing challenges within the dark proteome. The company was founded by its President Corey Dambacher and Ashley Woodfin. In March 2026, RyboDyn, Inc. raised USD 10 million in seed funding from Massive Tech Ventures Management, with participation from Genedant Capital, SeaX Ventures, SOSV, Swell Partners and Phase Two Capital. 

RyboDyn specializes in addressing complex challenges within proteomics with a focus on the dark proteome. The company offers solutions designed to explore previously difficult-to-analyze protein interactions and functions. The company’s primary offerings provide researchers and pharmaceutical companies with deeper insights into protein behavior, enhancing drug discovery and development processes. The firm's technologies caters end-users in academic research institutions, biotechnology firms, and pharmaceutical companies engaged in developing therapeutics targeting specific diseases.

RyboDyn generates revenue through strategic partnerships and B2B transactions primarily with research institutions and pharmaceutical companies requiring advanced proteomic solutions.

The company will use the May 2026 funding to expand target discovery and accelerate drug development.

## Funding rounds

- Seed, Mar 24, 2026, $10M — SOSV, SeaX Ventures, Swell Partners, Genedant Capital, Massive Tech Ventures Management, Phase Two Capital

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- SeaX Ventures (https://capitalatlas.ai/funds/seax-ventures) — Seed
- Swell Partners (https://capitalatlas.ai/funds/swell-partners) — Seed
- Genedant Capital (https://capitalatlas.ai/funds/genedant-capital) — Seed
- Massive Tech Ventures Management (https://capitalatlas.ai/funds/massive-tech-ventures-management) — Seed
- Phase Two Capital — Seed
